Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27363836 | 1.00 | CYP3A4 (0.43) | CYP3A4CYP1A2CYP2D6ATMMAPK9 | |
| SCHEMBL14380302 | 1.00 | CYP3A4 (0.43) | CYP3A4CYP1A2CYP2D6ATMMAPK9 | |
| SCHEMBL1758755 | 0.83 | MAOA (0.53) | CDC25BALDH1A1KMT2AMEN1CTSL | |
| SCHEMBL28696126 | 0.83 | CDC25B (0.53) | CDC25BALDH1A1TDP1KMT2AMEN1 | |
| SCHEMBL23503663 | 0.80 | MAPK9 (0.43) | ATMMAPK9MAPK10NCOA1NCOA3 | |
| SCHEMBL17878976 | 0.77 | ALDH1A1 (0.46) | CYP3A4CYP1A2CYP2D6ATMMAPK9 | |
| SCHEMBL20829704 | 0.77 | ATM (0.39) | CYP3A4CYP1A2CYP2D6ATMMAPK9 | |
| SCHEMBL20829703 | 0.77 | ATM (0.36) | CYP3A4CYP1A2CYP2D6ATMMAPK9 | |
| SCHEMBL22929944 | 0.75 | ATM (0.38) | CYP3A4CYP1A2ATMMAPK9MAPK10 | |
| SCHEMBL22891154 | 0.74 | GABRG2 (0.52) | CYP3A4CYP1A2CYP2D6MAPK9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038137-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-06-15 | — | — | US | disclosed |
| US-10910577-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-02 | — | — | US | disclosed |
| US-10566547-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10910577-B2 | Organic electroluminescent materials and devices | CACNA2D2, ORC3, ANO2 | CYP3A4 3127/4885CYP1A2 3460/4885CYP2D6 4461/4885 |
| US-10566547-B2 | Organic electroluminescent materials and devices | PAX2, EYA2, NLRP1 | CYP3A4 4206/4885CYP1A2 3676/4885CYP2D6 3994/4885 |
| US-20180013074-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PAX2, EYA2, NLRP1 | CYP3A4 4206/4885CYP1A2 3676/4885CYP2D6 3994/4885 |
| US-11038137-B2 | Organic electroluminescent materials and devices | ORC3, NUDC, AOC1 | CYP3A4 3097/4885CYP1A2 3387/4885CYP2D6 3229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.